Immune Modulation, Inc., a California-based biotech company founded in 1995, is translating a plant-derived compound into a drug candidate now being prepared for regulatory pathways in Parkinson's
Knowles (NYSE:KN – Get Free Report) released its quarterly earnings data on Thursday. The communications equipment provider reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.03, Briefing.com reports. The business had revenue of $153.10 million during the quarter,
Ageas SA (OTCMKTS:AGESY – Get Free Report)’s stock price hit a new 52-week high on Tuesday . The company traded as high as $81.0650 and last traded at $81.0650, with a volume of 534 shares trading hands. The stock had previously closed at $80.20. Ageas Price Performance
Idemitsu Kosan Co.,Ltd. (OTCMKTS:IDKOY – Get Free Report) shares dropped 12.7% during trading on Tuesday . The company traded as low as $18.07 and last traded at $18.07. Approximately 465 shares traded hands during trading, a decline of 88% from the average daily volume of 3,916
Fidelity NASDAQ Composite Index ETF (NASDAQ:ONEQ – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $96.53 and last traded at $95.95, with a volume of 114881 shares traded. The stock had previously closed at $96.09.
